产品名称:波形蛋白抗体,Anti-Vimentin抗体诚信服务
中文名称:波形蛋白抗体
英文名称:Anti-Vimentin
产品编号:byk-0756R
产品规格:0.1ml/0.2ml
产品用途:科研实验
性 状: Lyophilized or Liquid
浓 度: 1mg/1ml
亚 型: IgG
贮 存: 贮存于-20℃.
相关标记: HRP Biotin Gold RBITC AP FITC Cy3 Cy5 Cy5.5 Cy7 PE PE-Cy3 PE-CY5 PE-CY5.5 PE-CY7 APC Alexa Fluor 350 Alexa Fluor 488 Alexa Fluor 555 Alexa Fluor 647
我公司拥有领先的细胞服务技术,先进的仪器设备和专业的ELISA检测试剂盒、生物索标记、荧光索标记、酶标记等,广泛用于多种分析研究与技术测定。欢迎来电咨询,我们将竭诚为你服务!
波形蛋白抗体,Anti-Vimentin抗体诚信服务 相关产品:
白细胞介素-18受体β链抗体 Anti-IL-18R Beta/IL1R7/CD218b
蛇毒巴曲酶抗体 Anti-Batroxobin
巴曲霉毒素单克隆抗体 "Anti-Batroxobin(5H4)
"
尿调节蛋白抗体 Anti-MCKD2/UMOD
三磷酸腺苷依赖解旋酶DDX3抗体 Anti-DDX3
三聚氰胺抗体 Anti-Melamine
电压门控钾通道蛋白KVβ.2抗体 Anti-KCNA2B/Kv beta 2
斑联蛋白抗体 Anti-Zyxin/ESP 2
螺旋环螺旋转录因子HATH6抗体 Anti-HATH6
着丝粒蛋白抗体 Anti-ZW10 peptide
RAB3-GTP酶激活蛋白催化亚单位1抗体 Anti-RAB3GAP1
胞质紧密粘连蛋白1抗体(闭锁小带蛋白1) Anti-ZO-1
磷酸化非受体酪氨酸激酶c-Abl抗体 Anti-phospho-c-Abl(Tyr70)
锌指蛋白474抗体 Anti-ZNF474/ZFP106
RAB3-GTP酶激活蛋白催化亚单位2抗体 Anti-RAB3GAP2
锌指蛋白307抗体 Anti-ZNF307
维甲酸诱导蛋白1抗体 Anti-RAI1
锌指蛋白300抗体 Anti-ZNF300
锌指脂蛋白抗体 Anti-ZNF268
抗体规律
(1)初次反应产生抗体:当抗原一次进入机体时,需经一定的潜伏期才能产生抗体,且抗体产生的量也不多,在体内维持的时间也较短。
(2)再次反应产生抗体:当相同抗原第二次进入机体后,开始时,由于原有抗体中的一部分与再次进入的抗原结合,可使原有抗体量略为降低。随后,抗体效价迅速大量增加,可比初次反应产生的多几倍到几十倍,在体内留存的时间亦较长。
(3)回忆反应产生抗体:由抗原刺激机体产生的抗体,经过一定时间后可逐渐消失。此时若再次接触抗原,可使已消失的抗体快速上升。如再次刺激机体的抗原与初次相同,则称为特异性回忆反应;若与初次反应不同,则称为非特异性回忆反应。非特异性回忆反应引起的抗体的上升是暂时性的,短时间内即很快下降。
波形蛋白抗体,Anti-Vimentin抗体诚信服务 产品详情:
Vimentin is the major subunit protein of the intermediate filaments of mesenchymal cells. It is believed to be involved with the intracellular transport of proteins between the nucleus and plasma membrane. Vimentin has been implicated to be involved in the rate of steroid synthesis via its role as a storage network for steroidogenic cholesterol containing lipid droplets. Vimentin phosphorylation by a protein kinase causes the breakdown of intermediate filaments and activation of an ATP and myosin light chain-dependent contractile event. This results in cytoskeletal changes that facilitate the interaction of the lipid droplets within mitochondria, and subsequent transport of cholesterol to the organelles leading to an increase in steroid synthesis. Immunohistochemical staining for Vimentin is characteristic of sarcomas (of neural, muscle and fibroblast origin) compared with carcinomas which are generally negative. Melanomas, lymphomas and vascular tumors may all stain for Vimentin. Vimentin antibodies are thus of value in the differential diagnosis of undifferentiated neoplasms and malignant tumors. They are generally used with a panel of other antibodies including those recognizing cytokeratins, lymphoid markers, S100, desmin and neurofilaments.